Viatris Becomes 37th Manufacturer to Place Restrictions on 340B Contract Pharmacy Use; Policy Applies to Hospitals and Health Centers

Drug manufacturer Viatris has placed 340B contract pharmacy restrictions on hospitals and community health centers.
Canonsburg, Penn.-based Viatris yesterday became the 37th drugmaker to restrict the shipment of 340B-priced drugs in the contract pharmacy setting. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More Drugmakers Exempt States from Contract Pharmacy Restrictions as Four New State Laws Take Effect

Four major drug manufacturers announced they will fully or partially exempt covered entities in certain states from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Asks Federal Judge to Block Enforcement of Maryland’s New 340B Contract Pharmacy Access Law

PhRMA filed suit against Maryland's 340B contract pharmacy access law in a federal district court.
A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Higher Court Already Rejected AstraZeneca’s Claim on Arkansas 340B Contract Pharmacy Law, State Attorney Tells Federal Judge

The Arkansas Insurance Department filed a June 17 motion asking the U.S. District Court for Eastern Arkansas to dismiss AstraZeneca’s claim that Arkansas’ 340B contract pharmacy access law is preempted by the federal 340B statute.
A key argument in AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law has already been rejected by a higher [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Bash Novartis’ ‘Whiplash-Inducing’ Arguments in Mississippi 340B Contract Pharmacy Lawsuit

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Delaware House Passes 340B Contract Pharmacy Access Bill that Adds Reporting Requirements, Removes Protections for Hospitals

The Delaware House recently passed a 340B contract pharmacy access bill that removed protections for hospitals included in a previous version.
The Delaware House late last week overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions on grantee covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Op-Ed for Prominent Local Publication, Virginia Health Center Leader Pans Governor for Vetoing State 340B Protection Bill

Tracy Douglas, CEO of the Virginia Community Healthcare Association, penned an op-ed criticizing the state governor's decision to veto a 340B contract pharmacy access bill.
A leading Virginia health center advocate published an op-ed late last week blasting Gov. Glenn Youngkin (R) for choosing “Big [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Super PAC with Dark Money Ties Launches New Anti-340B Ad

Stand for Us PAC's latest ad threatens Republican politicians that support 340B and claims disputed credit for a key West Virginia lawmaker's recent primary loss.
A political action committee (PAC) with close ties to a dark money group recently released a new ad threatening to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law

Attorneys representing the drug industry, the state of Louisiana, and Louisiana health centers presented oral arguments before a federal district court.
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Ends or Loosens 340B Contract Pharmacy Restrictions in Four More States

Drugmaker Organon fully exempted West Virginia providers from its contract pharmacy policy and loosened its restrictions in three additional states.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live